CSHCN 2008 > Physician > Benefits and Limitations
Infliximab (procedure code 1-J1745) is a benefit of the CSHCN Services Program for the following diagnosis codes:
5550
Regional enteritis of small intestine
5551
Regional enteritis of large intestine
5552
Regional enteritis of small intestine with large intestine
5559
Regional enteritis of unspecified site
5651
Anal fistula
56981
Fistula of intestine, excluding rectum and anus
7140
Rheumatoid arthritis
7141
Felty's syndrome
7142
Other rheumatoid arthritis with visceral or systemic involvement
71430
Chronic or unspecified polyarticular juvenile rheumatoid arthritis
